Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: ADSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on ADSK, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 307 ADSK shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 307 shares
    Change vs previous 13F -13,151 shares

    <0.01% of the 13F portfolio, value $59,687.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 13,458 shares
    Change vs previous 13F -4,649 shares

    0.06% of the 13F portfolio, value $3,221,845.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 18,107 shares
    Change vs previous 13F -5,960 shares

    0.11% of the 13F portfolio, value $5,360,255.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 24,067 shares
    Change vs previous 13F +23,895 shares

    0.17% of the 13F portfolio, value $7,645,941.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 172 shares
    Change vs previous 13F +21 shares

    <0.01% of the 13F portfolio, value $53,250.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 151 shares
    Change vs previous 13F +13 shares

    <0.01% of the 13F portfolio, value $39,535.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 138 shares
    Change vs previous 13F +17 shares

    <0.01% of the 13F portfolio, value $40,792.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 121 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $33,335.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).